PSMA-Directed Theranostics in Prostate Cancer
Following lung cancer, prostate cancer is the leading cause of cancer death in men. High-risk localized tumor burden or metastatic disease often progresses, refractory to initial treatment regimens. There is ongoing development of technology to appropriately identify high-risk patients, stage them c...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2025-07-01
|
| Schriftenreihe: | Biomedicines |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2227-9059/13/8/1837 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|